Leukemia Stocks List

Recent Signals

Date Stock Signal Type
2021-06-23 ADPT Upper Bollinger Band Walk Strength
2021-06-23 AIKI 20 DMA Resistance Bearish
2021-06-23 AIKI Crossed Above 50 DMA Bullish
2021-06-23 AIKI Volume Surge Other
2021-06-23 AIKI Wide Range Bar Range Expansion
2021-06-23 AIKI Pocket Pivot Bullish Swing Setup
2021-06-23 AIKI Expansion Pivot Buy Setup Bullish Swing Setup
2021-06-23 AIKI Lower Bollinger Band Walk Weakness
2021-06-23 AIKI Bollinger Band Squeeze Range Contraction
2021-06-23 AIKI Lizard Bearish Bearish Day Trade Setup
2021-06-23 AIKI Shooting Star Candlestick Bearish
2021-06-23 ANIX 20 DMA Resistance Bearish
2021-06-23 ANIX Bollinger Band Squeeze Range Contraction
2021-06-23 BEAM Bollinger Band Squeeze Range Contraction
2021-06-23 BEAM NR7 Range Contraction
2021-06-23 BEAM Narrow Range Bar Range Contraction
2021-06-23 BEAM Pocket Pivot Bullish Swing Setup
2021-06-23 CASI Bollinger Band Squeeze Range Contraction
2021-06-23 CASI Stochastic Buy Signal Bullish
2021-06-23 CASI Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-06-23 CRDF Stochastic Reached Oversold Weakness
2021-06-23 CRDF Lower Bollinger Band Walk Weakness
2021-06-23 CRDF MACD Bearish Signal Line Cross Bearish
2021-06-23 CRDF Bollinger Band Squeeze Range Contraction
2021-06-23 EPZM Bollinger Band Squeeze Range Contraction
2021-06-23 ERYP 180 Bearish Setup Bearish Swing Setup
2021-06-23 ERYP New 52 Week Low Weakness
2021-06-23 ERYP Volume Surge Other
2021-06-23 ERYP New 52 Week Closing Low Bearish
2021-06-23 ERYP MACD Bearish Signal Line Cross Bearish
2021-06-23 INO Spinning Top Other
2021-06-23 NEXI Slingshot Bearish Bearish Swing Setup
2021-06-23 NEXI Stochastic Buy Signal Bullish
2021-06-23 NEXI Lower Bollinger Band Walk Weakness
2021-06-23 SYRS Stochastic Buy Signal Bullish
2021-06-23 SYRS Bollinger Band Squeeze Range Contraction
2021-06-23 TEVA NR7 Range Contraction
2021-06-23 TEVA Stochastic Buy Signal Bullish
2021-06-23 TEVA Narrow Range Bar Range Contraction
2021-06-23 VINC 180 Bearish Setup Bearish Swing Setup

Leukemia Stocks Recent News

Date Stock Title
Jun 23 ADPT Adaptive Biotechnologies (ADPT) Upgraded to Buy: Here's Why
Jun 23 AIKI AIkido Pharma Files Patent Application for the Use of Ketamine to Treat Alzheimer's Disease
Jun 23 TEVA Teva's Ajovy OK'd in Japan for preventive treatment of migraine in adults
Jun 23 TEVA Teva Announces Ministry of Health, Labour and Welfare Approves AJOVY® (fremanezumab) Injection in Japan for the Preventive Treatment of Migraine in Adults
Jun 23 TEVA Teva launches generic formoterol fumarate inhalation solution for lung disease in U.S.
Jun 23 INO Inovio Has 4 Sources Of Potential Value
Jun 22 TEVA Teva Announces Its Launch of the First Generic PERFOROMIST®, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used to Treat Chronic Obstructive Pulmonary Disease (COPD), in the United States
Jun 22 EPZM Epizyme: Potential Comeback With Tazemetostat After Initial Sales Challenge
Jun 22 CLLS Cellectis: FYE 2021 TALEN CAR-T Data Announcement Should Catalyse Strong Upside
Jun 22 TEVA Teva reports new Copaxone data in breastfeeding mothers with relapsing multiple sclerosis at EAN congress
Jun 22 TEVA New Safety Data on treatment with COPAXONE® (glatiramer acetate) of Breastfeeding Mothers who Live with Relapsing Multiple Sclerosis: COBRA study presented at the 7th Congress of the European Academy of Neurology (EAN)
Jun 21 INO Inovio Pharmaceuticals Could See a Boost from Covid-19 Partnerships
Jun 21 TEVA UPDATE 1-U.S. Supreme Court rebuffs AbbVie appeal in patent fight involving AndroGel drug
Jun 21 NEO Monday’s Pre-Market: Here’s What You Need to Know Before the Market Opens
Jun 21 TEVA Teva Presents New Data at 7th European Academy of Neurology Congress Suggesting Socio-Economic Factors May Contribute to the Significant Under-Diagnosis of Migraine
Jun 21 TEVA New Data Supporting the Safety and Efficacy Profile of AJOVY® (fremanezumab) Shared at 7th European Academy of Neurology Congress
Jun 21 NEO NeoGenomics Concludes Inivata Purchase Deal
Jun 21 INO Rock star Growth Puts Inovio Pharmaceuticals (NASDAQ:INO) In A Position To Use Debt
Jun 19 NEO PLDT Inc. (PHI): Hedge Fund Sentiment Unchanged
Jun 18 NEO NeoGenomics completes Inivata acquisition

Leukemia, also spelled leukaemia, is a group of cancers that usually begin in the bone marrow and result in high numbers of abnormal white blood cells. These white blood cells are not fully developed and are called blasts or leukemia cells. Symptoms may include bleeding and bruising problems, feeling tired, fever, and an increased risk of infections. These symptoms occur due to a lack of normal blood cells. Diagnosis is typically made by blood tests or bone marrow biopsy.The exact cause of leukemia is unknown. A combination of genetic factors and environmental (non-inherited) factors are believed to play a role. Risk factors include smoking, ionizing radiation, some chemicals (such as benzene), prior chemotherapy, and Down syndrome. People with a family history of leukemia are also at higher risk. There are four main types of leukemia—acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML)—as well as a number of less common types. Leukemias and lymphomas both belong to a broader group of tumors that affect the blood, bone marrow, and lymphoid system, known as tumors of the hematopoietic and lymphoid tissues.Treatment may involve some combination of chemotherapy, radiation therapy, targeted therapy, and bone marrow transplant, in addition to supportive care and palliative care as needed. Certain types of leukemia may be managed with watchful waiting. The success of treatment depends on the type of leukemia and the age of the person. Outcomes have improved in the developed world. The average five-year survival rate is 57% in the United States. In children under 15, the five-year survival rate is greater than 60 to 85%, depending on the type of leukemia. In children with acute leukemia who are cancer-free after five years, the cancer is unlikely to return.In 2015, leukemia was present in 2.3 million people and caused 353,500 deaths. In 2012 it newly developed in 352,000 people. It is the most common type of cancer in children, with three quarters of leukemia cases in children being the acute lymphoblastic type. However, about 90% of all leukemias are diagnosed in adults, with AML and CLL being most common in adults. It occurs more commonly in the developed world.

More about Leukemia
Browse All Tags